Antioxidant and anti-matrix metalloproteinases activities of dried longan (Euphoria longana) seed extract

ScienceAsia

Volumn 39, Issue 1, 2013, Pages 12-18

  Panyathep, Atita ^a   Chewonarin, Teera ^a   Taneyhill, Khanittha ^b   Vinitketkumnuen, Usanee ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

DPPH scavenging activity; Ellagic acid; Gallic acid; HPLC; Metal chelation activity; MMP inhibitor

Indexed keywords

EID: 84874897130     PISSN: 15131874     EISSN: None     Source Type: Journal    
DOI: 10.2306/scienceasia1513-1874.2013.39.012     Document Type: Article

References (44)

1. Rangkadilok N, Worasuttayangkurn L, Bennett RN, Satayavivad J (2005) Identification and quantification of polyphenolic compounds in longan (Euphoria longana Lam.) fruit. J Agr Food Chem 53, 1387-92.
2. Rangkadilok N, Sitthimonchai S, Worasuttayangkurn L, Mahidol C, Ruchirawat M, Satayavivad J (2007) Evaluation of free radical scavenging and antityrosinase activities of standardized longan fruit extract. Food Chem Toxicol 45, 328-36.
3. Raina K, Rajamanickam S, Deep G, Singh M, Agarwal R, Agarwal C (2008) Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice. Mol Canc Therapeut 7, 1258-67.
4. Yoshioka K, Kataoka T, Hayashi T, Hasegawa M, Ishi Y, Hibasami H (2000) Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol Rep 7, 1221-3.
5. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y (1994) Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Comm 204, 898-904.
6. Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, Yasuda N, Xinbin Q, Maruyama R, et al (1999) Induction of apoptosis by gallic acid in lung cancer cells. Anti Canc Drugs 10, 845-51.
7. Dorai T, Aggarwal BB (2004) Role of chemopreventive agents in cancer therapy. Canc Lett 215, 129-40.
8. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360-7.
9. Stoner GD, Mukhtar H (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 22, 169-80.
10. Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, Cozzi R (2001) Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res 21, 3903-8.
11. Banzouzi JT, Prado R, Menan H, Valentin A, Roumestan C, Mallie M, Pelissier Y, Blache Y (2002) In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid. J Ethnopharmacol 81, 399-401.
12. Yu YM, Chang WC,Wu CH, Chiang SY (2005) Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid. J Nutr Biochem 16, 675-81.
13. Nagase H, Woessner JF, Jr (1999) Matrix metalloproteinases. J Biol Chem 274, 21491-4.
14. Bode W, Maskos K (2003) Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases. Biol Chem 384, 863-72.
15. Maskos K (2005) Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Biochimie 87, 249-63.
16. Zhang C, Kim SK (2009) Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects. Mar Drugs 7, 71-84.
17. Grant GA, Goldberg GI, Wilhelm SM, He C, Eisen AZ (1992) Activation of extracellular matrix metalloproteases by proteases and organomercurials. Matrix Suppl 1, 217-23.
18. Somerville RP, Oblander SA, Apte SS (2003) Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4, 216.
19. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Brivida K, Oberley TD, Scharffetter-Kochanek K (1999) Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 274, 25869-76.
20. Buhimschi IA, Kramer WB, Buhimschi CS, Thompson LP, Weiner CP (2000) Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. Am J Obstet Gynecol 182, 458-64.
21. Sang QX, Jin Y, Newcomer RG, Monroe SC, Fang X, Hurst DR, Lee S, Cao Q, et al (2006) Matrix metalloproteinase inhibitors as prospective agents for the prevention and treatment of cardiovascular and neoplastic diseases. Curr Top Med Chem 6, 289-316.
22. Oskoueian E, Abdullah N, Hendra R, Karimi E (2011) Bioactive compounds, antioxidant, xanthine oxidase inhibitory, tyrosinase inhibitory and anti-inflammatory activities of selected agro-industrial by-products. Int J Mol Sci 12, 8610-25.
23. Hendra R, Ahmad S, Oskoueian E, Sukari A, Shukor MY (2011) Antioxidant, anti-inflammatory and cytotoxicity of Phaleria macrocarpa (Boerl.) Scheff Fruit. BMC Compl Alternat Med 11, 110.
24. Duan X, Wu G, Jiang Y (2007) Evaluation of the antioxidant properties of litchi fruit phenolics in relation to pericarp browning prevention. Molecules 12, 759-71.
25. Sarni-Manchado P, Le Roux E, Le Guerneve C, Lozano Y, Cheynier V (2000) Phenolic composition of litchi fruit pericarp. J Agr Food Chem 48, 5995-6002.
26. Dinis TC, Maderia VM, Almeida LM (1994) Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch Biochem Biophys 315, 161-9.
27. Kawada M, Ohno Y, Ri Y, Ikoma T, Yuugetu H, Asai T, Watanabe M, Yasuda N, et al (2001) Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anti Canc Drugs 12, 847-52.
28. Lee KW, Hur HJ, Lee HJ, Lee CY (2005) Antiproliferative effects of dietary phenolic substances and hydrogen peroxide. J Agr Food Chem 53, 1990-5.
29. Losso JN, Bansode RR, Trappey A, 2nd Bawadi HA, Truax R (2004) In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15, 672-8.
30. Saleem A, Husheem M, Harkonen P, Pihlaja K (2002) Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J Ethnopharmacol 81, 327-36.
31. Soong YY, Barlow PJ (2005) Isolation and structure elucidation of phenolic compounds from longan (Dimocarpus longan Lour.) seed by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chrom A 1085, 270-7.
32. Seo UK, Lee YJ, Kim JK, Cha BY, Kim DW, Nam KS, Kim CH (2005) Large-scale and effective screening of Korean medicinal plants for inhibitory activity on matrix metalloproteinase-9. J Ethnopharmacol 97, 101-6.
33. Ha KT, Lee TK, Kwak KH, Kim JK, Kim DI, Choi DY, Kim CH (2004) Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity. Vasc Pharmacol 41, 83-90.
34. Ha KT, Kim JK, Kang SK, Kim DW, Lee YC, Kim HM, Kim CH (2004) Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma. Pharmacol Res 50, 279-85.
35. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Canc 2, 657-72.
36. Overall CM, Kleifeld O (2006) Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Canc 6, 227-39.
37. Overall CM, Blobel CP (2007) In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 8, 245-57.
38. Wasserman ZR (2005) Making a new turn in matrix metalloprotease inhibition. Chem Biol 12, 143-4.
39. Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, et al (2005) Structural basis for the highly selective inhibition of MMP-13. Chem Biol 12, 181-9.
40. Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compere D, Denis A, Blais S, et al (2005) Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors. Bioorg Med Chem Lett 15, 3787-90.
41. Ende C, Gebhardt R (2004) Inhibition of matrix metalloproteinase-2 and -9 activities by selected flavonoids. Planta Med 70, 1006-8.
42. Mannello F (2006) Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon? Recent Patents Anti Canc Drug Discov 1, 91-103.
43. Whittaker M, Floyd CD, Brown P, Gearing AJ (1999) Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99, 2735-76.
44. Lee S, Park HI, Sang QX (2007) Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion. Biochem J 403, 31-42.